Search

Your search keyword '"Finke, Jürgen"' showing total 75 results
Start Over Author "Finke, Jürgen" Publisher elsevier bv
75 results on '"Finke, Jürgen"'

1. Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy

Author

Dertschnig, Simone, primary, Gergely, Peter, additional, Finke, Jürgen, additional, Schanz, Urs, additional, Holler, Ernst, additional, Holtick, Udo, additional, Socié, Gérard, additional, Medinger, Michael, additional, Passweg, Jakob, additional, Teshima, Takanori, additional, Stylianou, Christos, additional, Oehen, Stephan, additional, Heim, Dominik, additional, and Bucher, Christoph, additional

Published
2023
Full Text
View/download PDF

2. High-Dose Chemotherapy and Autologous Stem Cell Transplant in Elderly and Fit PCNSL Patients – The Multicenter MARTA Study

Author

Schorb, Elisabeth, primary, Isbell, Lisa Kristina, additional, Kerkhoff, Andrea, additional, Mathas, Stephan, additional, Braulke, Friederike, additional, Egerer, Gerlinde, additional, Röth, Alexander, additional, Schliffke, Simon, additional, Borchmann, Peter, additional, Brunnberg, Uta, additional, Kroschinsky, Frank P., additional, Möhle, Robert, additional, Rank, Andreas, additional, Wellnitz, Dominique, additional, Kasenda, Benjamin, additional, Pospiech, Lisa, additional, Wendler, Julia, additional, Scherer, Florian, additional, Deckert, Martina, additional, Henkes, Elina, additional, von Gottberg, Philipp, additional, Gmehlin, Dennis, additional, Backenstrass, Matthias, additional, Jensch, Antje, additional, Burger-Martin, Elvira, additional, Grishina, Olga, additional, Fricker, Heidi, additional, Malenica, Natalie, additional, Orban, Andras, additional, Duyster, Justus, additional, Ihorst, Gabriele, additional, Finke, Jürgen, additional, and Illerhaus, Gerald, additional

Published
2023
Full Text
View/download PDF

3. Long-Term Results of Allogeneic Stem Cell Transplantation in Adult Ph- Negative High-Risk Acute Lymphoblastic Leukemia

Author

Beelen, Dietrich W., primary, Arnold, Renate, additional, Stelljes, Matthias, additional, Alakel, Nael, additional, Brecht, Arne, additional, Bug, Gesine, additional, Bunjes, Donald, additional, Faul, Christoph, additional, Finke, Jürgen, additional, Franke, Georg-Nikolaus, additional, Holler, Ernst, additional, Kobbe, Guido, additional, Kröger, Nicolaus, additional, Rösler, Wolf, additional, Scheid, Christof, additional, Schönland, Stefan, additional, Stadler, Michael, additional, Tischer, Johanna, additional, Wagner-Drouet, Eva, additional, Wendelin, Knut, additional, Brüggemann, Monika, additional, Reiser, Lena, additional, Hoelzer, Dieter, additional, and Gökbuget, Nicola, additional

Published
2022
Full Text
View/download PDF

4. Favourable Outcome after Treosulfan Based Conditioning of Patients Receiving an Allogeneic Hematopoietic Cell Transplantation (AlloHCT) for the Treatment of a Myelodysplastic Syndrome (MDS)

Author

Stelljes, Matthias, primary, Trenschel, Rudolf, additional, Beelen, Dietrich Wilhelm, additional, Markiewicz, Miroslaw, additional, Wagner, Eva Maria, additional, Bethge, Wolfgang, additional, Remenyi, Peter, additional, Niederwieser, Dietger, additional, Grigoleit, Goetz, additional, Schaefer-Eckart, Kerstin, additional, Stölzel, Friedrich, additional, Ciceri, Fabio, additional, Dreger, Peter, additional, Junghanß, Christian, additional, Holler, Ernst, additional, Rambaldi, Alessandro, additional, Russo, Domenico, additional, Verbeek, Mareike, additional, Casper, Jochen, additional, Patriarca, Francesca, additional, Bieniaszewska, Maria, additional, Glass, Bertram, additional, Scheid, Christoph, additional, Basara, Nadezda, additional, Finke, Jürgen, additional, Hilgendorf, Inken, additional, Labussière-Wallet, Hélène, additional, Stuhler, Gernot, additional, and Schroeder, Thomas, additional

Published
2022
Full Text
View/download PDF

5. Evaluation of Trends in Outcome over 2 Decades of Patients with Relapsed/Refractory Acute Myelogenous Leukemia Undergoing Allogeneic Stem Cell Transplantation from Unrelated Donors: An ALWP/EBMT Analysis

Author

Nagler, Arnon, primary, Ngoya, Maud, additional, Labopin, Myriam, additional, Bornhauser, Martin, additional, Stelljes, Matthias, additional, Finke, Jürgen, additional, Ganser, Arnold, additional, Einsele, Hermann, additional, Kroger, Nicolaus, additional, Brecht, Arne, additional, Bethge, Wolfgang, additional, Edinger, Matthias, additional, Kulagin, Aleksandr, additional, Passweg, Jakob, additional, Elmaagacli, Ahmet, additional, Schafer-Eckart, K., additional, Platzbecker, Uwe, additional, Schroeder, Thomas, additional, Bunjes, Donald, additional, Tischer, Johanna, additional, Martin, Sonja, additional, Spyridonidis, Alexandros, additional, Giebel, Sebastian, additional, Savani, Bipin, additional, and Mohty, Mohamad, additional

Published
2022
Full Text
View/download PDF

7. Role of Age and Hematopoietic Cell Transplantation-Specific Comorbidity Index in Myelodysplastic Patients Undergoing an Allotransplant: A Retrospective Study from the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

Author

Carré, Martin, Porcher, Raphaël, Finke, Jürgen, Ehninger, Gerhard, Koster, Linda, Beelen, Dietrich, Ganser, Arnold, Volin, Liisa, Lozano, Sara, Friis, Lone, Michallet, Mauricette, Tischer, Johanna, Olavarria, Eduardo, Cascon, Maria Jesús Pascual, Iacobelli, Simona, Koc, Yener, Jindra, Pavel, Arat, Mutlu, de Witte, Theo, Yakoub Agha, Ibrahim, Kröger, Nicolaus, Robin, Marie, and Agha, Ibrahim Yakoub

Subjects
Adult, medicine.medical_specialty, Transplantation Conditioning, Multivariate analysis, Cancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2], medicine.medical_treatment, Myelodysplastic syndromes, Medizin, Comorbidity, Hematopoietic stem cell transplantation, Comorbidities, 03 medical and health sciences, All institutes and research themes of the Radboud University Medical Center, Age, 0302 clinical medicine, Bone Marrow, Neoplasms, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Retrospective Studies, Transplantation, Nonrelapse mortality, business.industry, Hazard ratio, Hematopoietic Stem Cell Transplantation, Retrospective cohort study, Hematology, Settore MED/15, medicine.disease, Settore MED/01, 030220 oncology & carcinogenesis, Stem cell, business, 030215 immunology
Abstract

Allogeneic hematopoietic stem cell transplantation (HSCT) remains the only potentially curative option for myelodysplastic syndromes (MDSs) but is severely limited by nonrelapse mortality (NRM), especially in this mostly older population. Comorbidity assessment is crucial to predict NRM and often assessed with the Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI). Moreover, the impact of age on NRM still remains a matter of debate. In recent years, the age at which transplants are made has been progressively increasing, and patients with comorbidities have become more common. Extricating the respective roles of age and comorbidities in toxic mortality is all the more important. This study by the European Group for Blood and Marrow Transplantation registry included 1245 adult patients who underwent a first allogeneic stem cell transplantation for MDSs between 2003 and 2014. Overall, 4-year NRM and overall survival were 32% and 47%, respectively. When considered as continuous predictors, HCT-CI score and age were associated with an increased hazard ratio (HR) for NRM. In multivariate analysis, age band (HR, 1.13; 95% CI, 1.02 to 1.25; P= .016), HCT-CI ≥3 (HR, 1.34; 95% CI, 1.04 to 1.73; P = .022), and Karnofsky Performance Status ≤80 (HR, 2.03; 95% CI, 1.52 to 2.73; P.0001) were significantly predictive of a worse NRM. In our large cohort, both comorbidities, evaluated by the original HCT-CI score, and chronological age significantly affected NRM. Thus, age should be part of the transplant decision-making process and should be integrated in future scoring systems predicting outcomes of HSCT in MDSs.

Published
2020

8. Feasibility and Outcomes of a Third Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Author

Rank, Andreas, primary, Peczynski, Christophe, additional, Labopin, Myriam, additional, Stelljes, Matthias, additional, Simand, Celestine, additional, Helbig, Grzegorz, additional, Finke, Jürgen, additional, Santarone, Stella, additional, Tischer, Johanna, additional, Lange, Andrzej, additional, Mistrik, Martin, additional, Houhou, Mohamed, additional, Schmid, Christoph, additional, Nagler, Arnon, additional, and Mohty, Mohamad, additional

Published
2021
Full Text
View/download PDF

9. FLAMSA-Based Reduced-Intensity Conditioning versus Myeloablative Conditioning in Younger Patients with Relapsed/Refractory Acute Myeloid Leukemia with Active Disease at the Time of Allogeneic Stem Cell Transplantation: An Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Author

Instituto de Salud Carlos III, Rodríguez-Arbolí, Eduardo, Labopin, Myriam, Tischer, Johanna, Brecht, Arne, Finke, Jürgen, Wolfgang Blau, Igor, Kroger, Nicolaus, Kalhs, Peter, Forcade, Edouard, Bunjes, Donald, Spyridonidis, Alexandros, Savani, Bipin, Nagler, Arnon, Mohty, Mohamad, Instituto de Salud Carlos III, Rodríguez-Arbolí, Eduardo, Labopin, Myriam, Tischer, Johanna, Brecht, Arne, Finke, Jürgen, Wolfgang Blau, Igor, Kroger, Nicolaus, Kalhs, Peter, Forcade, Edouard, Bunjes, Donald, Spyridonidis, Alexandros, Savani, Bipin, Nagler, Arnon, and Mohty, Mohamad

Abstract

The use of myeloablative conditioning (MAC) in the setting of active relapsed/refractory (R/R) acute myeloid leukemia (AML) has been hindered by high historical rates of nonrelapse mortality (NRM). FLAMSA (fludarabine, Ara-C, and amsacrine) chemotherapy (CT) followed by reduced-intensity conditioning (RIC) has been proposed as an effective and potentially safer alternative in this scenario. As improvements in supportive care have contributed to decreasing NRM rates after MAC, a comparative reassessment of these two strategies was performed. This was a registry-based analysis by the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Eligibility criteria included age 18 to 50 years, primary refractory, first or second relapsed active AML, first allogeneic stem cell transplantation from a matched sibling donor (MSD) or an unrelated donor (UD) performed between 2005 and 2018, MAC or FLAMSA-RIC. A total of 1018 patients were included. The median patient age was 39 years (range, 18 to 50). Two hundred and fifty-eight patients received busulfan (Bu)/cyclophosphamide (Cy), 314 received Cy/total body irradiation (TBI), 318 received FLAMSA-TBI, and 128 received FLAMSA-CT. The median duration of follow-up was 50 months. In univariate analysis, the 2-year relapse incidence (RI) (54%; 95% confidence interval (CI), 50%-57%), leukemia-free survival (LFS) (30%; 95% CI, 27%-33%), and refined graft-versus-host disease-free, relapse-free survival (GRFS) (21%; 95% CI, 18%-24%) were not significantly different between cohorts. Lower 2-year NRM was observed in the FLAMSA-CT group (7% versus 16% in Bu/Cy, 19% in Cy/TBI, and 18% in FLAMSA-TBI; P = .04), as well as increased 2-year overall survival (OS) (50% versus 33% in Bu/Cy, 34% in Cy/TBI, and 36% in FLAMSA-TBI; P = .03). These results were maintained in the multivariate analysis (hazard ratio [HR] for NRM: .40, P = .01; HR for OS: .65, P = .01; Bu/Cy as reference). These data suggest that FLAMSA

Published
2020

10. Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm after Breast Cancer: A Study of the Chronic Malignancies Working Party of the EBMT

Author

Nabergoj, Mitja, primary, Mauff, Katya, additional, Beelen, Dietrich, additional, Ganser, Arnold, additional, Krogër, Nicolaus, additional, Stölzel, Friedrich, additional, Finke, Jürgen, additional, Passweg, Jakob, additional, Cornelissen, Jan, additional, Schub, Natalie, additional, Veelken, Joan Hendrik, additional, Beguin, Yves, additional, Wilson, Keith, additional, Zuckerman, Tsila, additional, Hunault-Berger, Mathilde, additional, Lioure, Bruno, additional, Parody, Rocio, additional, Turlure, Pascal, additional, Kerre, Tessa, additional, Koster, Linda, additional, Hayden, Patrick J., additional, Onida, Francesco, additional, Scheid, Christof, additional, Chalandon, Yves, additional, Robin, Marie, additional, and Yakoub-Agha, Ibrahim, additional

Published
2021
Full Text
View/download PDF

11. Long-Term Survival Benefit after Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia

Author

Gagelmann, Nico, primary, Bogdanov, Rashit, additional, Stölzel, Friedrich, additional, Rautenberg, Christina, additional, Panagiota, Victoria, additional, Becker, Heiko, additional, Radujkovic, Aleksandar, additional, Luft, Thomas, additional, Christopeit, Maximilian, additional, Finke, Jürgen, additional, Platzbecker, Uwe, additional, Ditschkowski, Markus, additional, Schroeder, Thomas, additional, Koldehoff, Michael, additional, Heuser, Michael, additional, Kobbe, Guido, additional, Beelen, Dietrich W., additional, Germing, Ulrich, additional, and Kröger, Nicolaus, additional

Published
2021
Full Text
View/download PDF

12. Prevalence and characteristics of myeloproliferative neoplasms with concomitant monoclonal gammopathy

Author

Javorniczky, Nora Rebeka, primary, Wehrle, Julius, additional, Ihorst, Gabriele, additional, Hupfer, Valerie, additional, Aumann, Konrad, additional, Pfeifer, Dietmar, additional, Niemöller, Christoph, additional, Bleul, Sabine, additional, Pantic, Milena, additional, Werner, Martin, additional, Duyster, Justus, additional, Finke, Jürgen, additional, Engelhardt, Monika, additional, von Bubnoff, Nikolas, additional, Waller, Cornelius F., additional, Pahl, Heike L., additional, and Becker, Heiko, additional

Published
2020
Full Text
View/download PDF

13. FLAMSA-Based Reduced-Intensity Conditioning versus Myeloablative Conditioning in Younger Patients with Relapsed/Refractory Acute Myeloid Leukemia with Active Disease at the Time of Allogeneic Stem Cell Transplantation: An Analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Author

Rodríguez-Arbolí, Eduardo, primary, Labopin, Myriam, additional, Tischer, Johanna, additional, Brecht, Arne, additional, Ganser, Arnold, additional, Finke, Jürgen, additional, Blau, Igor Wolfgang, additional, Kröger, Nicolaus, additional, Kalhs, Peter, additional, Forcade, Edouard, additional, Bunjes, Donald, additional, Spyridonidis, Alexandros, additional, Savani, Bipin, additional, Nagler, Arnon, additional, and Mohty, Mohamad, additional

Published
2020
Full Text
View/download PDF

15. Allogeneic Stem Cell Transplantation from Two Loci Mismatched (≤6/8) Unrelated Donors in Acute Leukemia: On Behalf of the ALWP of the EBMT

Author

Nagler, Arnon, primary, Labopin, Myriam, additional, Bruno, Benedetto, additional, Rambaldi, Alessandro, additional, Pioltelli, Pietro, additional, la Nasa, Giorgio, additional, Socié, Gerard, additional, Mielke, Stephan, additional, Ruggeri, Marco, additional, Saccardi, Riccardo, additional, Platzbecker, Uwe, additional, Finke, Jürgen, additional, Ruggeri, Annalisa, additional, Savani, Bipin, additional, and Mohty, Mohamad, additional

Published
2020
Full Text
View/download PDF

16. Allogeneic Stem Cell Transplantation for AML Patients with RUNX1 Mutation in First Complete Remission: A Study on Behalf of the ALWP of the EBMT

Author

Waidhauser, Johanna, primary, Labopin, Myriam, additional, Esteve, Jordi, additional, Kröger, Nicolaus, additional, Cornelissen, Jan, additional, Gedde-Dahl, Tobias, additional, Van Gorkom, Gwendolyn, additional, Finke, Jürgen, additional, Rovira, Montserrat, additional, Schaap, Nicolaas, additional, Petersen, Eefke, additional, Beelen, Dietrich Wilhelm, additional, Bunjes, Donald W., additional, Schmid, Christoph, additional, Nagler, Arnon, additional, and Mohty, Mohamad, additional

Published
2020
Full Text
View/download PDF

18. Comparable Long-Term Outcome after Allogeneic Stem Cell Transplantation from Sibling and Matched Unrelated Donors in Patients with Acute Myeloid Leukemia Older Than 50 Years: A Report on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Author

Shimoni, Avichai, primary, Labopin, Myriam, additional, Savani, Bipin, additional, Byrne, Michael, additional, Volin, Liisa, additional, Finke, Jürgen, additional, Niederwieser, Dietger, additional, Ehninger, Gerhard, additional, Blaise, Didier, additional, Beelen, Dietrich, additional, Tabrizi, Reza, additional, Sengeloev, Henrik, additional, Ganser, Arnold, additional, Cornelissen, Jan J., additional, Mohty, Mohamad, additional, and Nagler, Arnon, additional

Published
2019
Full Text
View/download PDF

19. Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Author

McLornan, Donal, primary, Szydlo, Richard, additional, Koster, Linda, additional, Chalandon, Yves, additional, Robin, Marie, additional, Wolschke, Christine, additional, Beelen, Dietrich, additional, Socié, Gerard, additional, Bornhäuser, Martin, additional, Angelucci, Emanuele, additional, Niederwieser, Dietger, additional, Gerbitz, Arnim, additional, Finke, Jürgen, additional, Vitek, Antonin, additional, Itälä-Remes, Maija, additional, Radujkovic, Aleksandar, additional, Kanz, Lothar, additional, Potter, Victoria, additional, Chevallier, Patrice, additional, Stelljes, Matthias, additional, Petersen, Eefke, additional, Robinson, Stephen, additional, Poiré, Xavier, additional, Klyuchnikov, Evgeny, additional, Hernández-Boluda, Juan Carlos, additional, Czerw, Tomasz, additional, Hayden, Patrick, additional, Kröger, Nicolaus, additional, and Yakoub-Agha, Ibrahim, additional

Published
2019
Full Text
View/download PDF

20. Allogeneic Stem Cell Transplantation for Blast Crisis Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: A Retrospective Study by the EBMT Chronic Malignancies Working Party

Author

Radujkovic, Aleksandar, primary, Dietrich, Sascha, additional, Blok, Henric-Jan, additional, Nagler, Arnon, additional, Ayuk, Francis, additional, Finke, Jürgen, additional, Tischer, Johanna, additional, Mayer, Jiri, additional, Koc, Yener, additional, Sorà, Federica, additional, Passweg, Jakob, additional, Byrne, Jenny L., additional, Jindra, Pavel, additional, Veelken, Joan Hendrik, additional, Socié, Gerard, additional, Maertens, Johan, additional, Schaap, Nicolaas, additional, Stadler, Michael, additional, Itälä-Remes, Maija, additional, Tholouli, Eleni, additional, Arat, Mutlu, additional, Rocha, Vanderson, additional, Ljungman, Per, additional, Yakoub-Agha, Ibrahim, additional, Kröger, Nicolaus, additional, and Chalandon, Yves, additional

Published
2019
Full Text
View/download PDF

21. Biology-Driven Approaches to Prevent and Treat Relapse of Myeloid Neoplasia after Allogeneic Hematopoietic Stem Cell Transplantation

Author

Zeiser, Robert, primary, Beelen, Dietrich W., additional, Bethge, Wolfgang, additional, Bornhäuser, Martin, additional, Bug, Gesine, additional, Burchert, Andreas, additional, Christopeit, Maximilian, additional, Duyster, Justus, additional, Finke, Jürgen, additional, Gerbitz, Armin, additional, Klusmann, Jan Henning, additional, Kobbe, Guido, additional, Lübbert, Michael, additional, Müller-Tidow, Carsten, additional, Platzbecker, Uwe, additional, Rösler, Wolf, additional, Sauer, Martin, additional, Schmid, Christoph, additional, Schroeder, Thomas, additional, Stelljes, Mathias, additional, Kröger, Nicolaus, additional, and Müller, Lutz P., additional

Published
2019
Full Text
View/download PDF

22. The Role of Donor Selection for a Second Allogeneic Stem Cell Transplantation in Patients with AML Relapsing after a First Transplant; A Study on Behalf of the Acute Leukemia Working Party of EBMT

Author

Shimoni, Avichai, primary, Labopin, Myriam, additional, Finke, Jürgen, additional, Ciceri, Fabio, additional, Deconinck, Eric, additional, Kroger, Nicolaus, additional, Gramatzki, Martin, additional, Stelljes, Matthias, additional, Blaise, Didier, additional, Stölzel, Friedrich, additional, Chevallier, Patrice, additional, Holler, Ernst, additional, Fegueux, Nathalie, additional, Mohty, Mohamad, additional, and Nagler, Arnon, additional

Published
2019
Full Text
View/download PDF

23. Final Evaluation of a Clinical Phase III Trial Comparing Treosulfan to Busulfan-Based Conditioning Therapy Prior to Allogeneic Hematopoietic Stem Cell Transplantation of Adult Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients Ineligible to Standard Myeloablative Regimens

Author

Beelen, Dietrich, primary, Markiewicz, Miroslaw, additional, Stelljes, Matthias, additional, Remenyi, Peter, additional, Wagner-Drouet, Eva-Maria, additional, Dreger, Peter, additional, Bethge, Wolfgang, additional, Ciceri, Fabio, additional, Stölzel, Friedrich, additional, Junghanß, Christian, additional, Michallet, Mauricette, additional, Schaefer-Eckart, Kerstin, additional, Grigoleit, Goetz, additional, Scheid, Christof, additional, Patriarca, Francesca, additional, Mico, Maria Caterina, additional, Niederwieser, Dietger, additional, Hilgendorf, Inken, additional, Russo, Domenico, additional, Socié, Gerard, additional, Holler, Ernst, additional, Glass, Bertram, additional, Wulf, Gerald, additional, Basara, Nadezda, additional, Hellmann, Andrzej, additional, Stuhler, Gernot, additional, Verbeek, Mareike, additional, Iori, Anna Paola, additional, Finke, Jürgen, additional, Benedetti, Fabio, additional, and Casper, Jochen, additional

Published
2019
Full Text
View/download PDF

24. GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study

Author

Bonifazi, Francesca, primary, Solano, Carlos, additional, Wolschke, Christine, additional, Sessa, Mariarosaria, additional, Patriarca, Francesca, additional, Zallio, Francesco, additional, Nagler, Arnon, additional, Selleri, Carmine, additional, Risitano, Antonio Maria, additional, Messina, Giuseppe, additional, Bethge, Wolfgang, additional, Herrera, Pilar, additional, Sureda, Anna, additional, Carella, Angelo Michele, additional, Cimminiello, Michele, additional, Guidi, Stefano, additional, Finke, Jürgen, additional, Sorasio, Roberto, additional, Ferra, Christelle, additional, Sierra, Jorge, additional, Russo, Domenico, additional, Benedetti, Edoardo, additional, Milone, Giuseppe, additional, Benedetti, Fabio, additional, Heinzelmann, Marion, additional, Pastore, Domenico, additional, Jurado, Manuel, additional, Terruzzi, Elisabetta, additional, Narni, Franco, additional, Völp, Andreas, additional, Ayuk, Francis, additional, Ruutu, Tapani, additional, and Kröger, Nicolaus, additional

Published
2019
Full Text
View/download PDF

25. HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis

Author

Robin, Marie, primary, Porcher, Raphaël, additional, Ruggeri, Annalisa, additional, Blaise, Didier, additional, Wolschke, Christine, additional, Koster, Linda, additional, Angelucci, Emanuele, additional, Stölzel, Friedrich, additional, Potter, Victoria, additional, Yakoub-Agha, Ibrahim, additional, Koc, Yener, additional, Ciceri, Fabio, additional, Finke, Jürgen, additional, Labussière-Wallet, Hélène, additional, Cascon, Maria Jesús Pascual, additional, Verbeek, Mareike, additional, Rambaldi, Alessandro, additional, Cornelissen, Jan J., additional, Chevallier, Patrice, additional, Radia, Rohini, additional, Nagler, Arnon, additional, Fegueux, Nathalie, additional, Gluckman, Eliane, additional, de Witte, Theo, additional, and Kröger, Nicolaus, additional

Published
2019
Full Text
View/download PDF

26. Relative Impact of HLA Matching and Non-HLA Donor Characteristics on Outcomes of Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome

Author

Ayuk, Francis, primary, Beelen, Dietrich W., additional, Bornhäuser, Martin, additional, Stelljes, Matthias, additional, Zabelina, Tatjana, additional, Finke, Jürgen, additional, Kobbe, Guido, additional, Wolff, Daniel, additional, Wagner, Eva-Maria, additional, Christopeit, Maximilian, additional, Schmid, Christoph, additional, Ottinger, Hellmut, additional, Groth, Christoph, additional, Faul, Christoph, additional, Bertz, Hartmut, additional, Rachlis, Elena, additional, Wolschke, Christine, additional, Schetelig, Johannes, additional, Horn, Peter A., additional, Mytilineos, Joannis, additional, Guellstorf, Martina, additional, Kelsch, Reinhard, additional, Fleischhauer, Katharina, additional, Kröger, Nicolaus, additional, and Bethge, Wolfgang, additional

Published
2018
Full Text
View/download PDF

27. Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning

Author

Duque-Afonso, Jesús, primary, Ihorst, Gabriele, additional, Waterhouse, Miguel, additional, Zeiser, Robert, additional, Wäsch, Ralph, additional, Bertz, Hartmut, additional, Müller-Quernheim, Joachim, additional, Finke, Jürgen, additional, Marks, Reinhard, additional, and Prasse, Antje, additional

Published
2018
Full Text
View/download PDF

28. Decitabine in combination with donor lymphocyte infusions can induce remissions in relapsed myeloid malignancies with higher leukemic burden after allogeneic hematopoietic cell transplantation

Author

Sommer, Sebastian, primary, Cruijsen, Marjan, additional, Claus, Rainer, additional, Bertz, Hartmut, additional, Wäsch, Ralph, additional, Marks, Reinhard, additional, Zeiser, Robert, additional, Bogatyreva, Lioudmila, additional, Blijlevens, Nicole M.A., additional, May, Annette, additional, Duyster, Justus, additional, Huls, Gerwin, additional, van der Velden, Walter J.F.M., additional, Finke, Jürgen, additional, and Lübbert, Michael, additional

Published
2018
Full Text
View/download PDF

29. Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study

Author

Sengsayadeth, Salyka, primary, Labopin, Myriam, additional, Boumendil, Ariane, additional, Finke, Jürgen, additional, Ganser, Arnold, additional, Stelljes, Matthias, additional, Ehninger, Gerhard, additional, Beelen, Dietrich, additional, Niederwieser, Dietger, additional, Blaise, Didier, additional, Dreger, Peter, additional, Mufti, Ghulam, additional, Chevallier, Patrice, additional, Mailhol, Audrey, additional, Gatwood, Katie S., additional, Gorin, Norbert, additional, Esteve, Jordi, additional, Ciceri, Fabio, additional, Baron, Frederic, additional, Schmid, Christoph, additional, Giebel, Sebastian, additional, Mohty, Mohamad, additional, Savani, Bipin N., additional, and Nagler, Arnon, additional

Published
2018
Full Text
View/download PDF

30. Allogeneic Stem Cell Transplantation for Myelodysplastic Syndrome Patients with a 5q Deletion

Author

Garderet, Laurent, primary, Ziagkos, Dimitris, additional, van Biezen, Anja, additional, Iacobelli, Simona, additional, Finke, Jürgen, additional, Maertens, Johan, additional, Volin, Liisa, additional, Ljungman, Per, additional, Chevallier, Patrice, additional, Passweg, Jakob, additional, Schaap, Nicolaas, additional, Beelen, Dietrich, additional, Nagler, Arnon, additional, Blaise, Didier, additional, Poiré, Xavier, additional, Yakoub-Agha, Ibrahim, additional, Lenhoff, Stig, additional, Craddock, Charles, additional, Schots, Rik, additional, Rambaldi, Alessandro, additional, Sanz, Jaime, additional, Jindra, Pavel, additional, Mufti, Ghulam J., additional, Robin, Marie, additional, and Kröger, Nicolaus, additional

Published
2018
Full Text
View/download PDF

31. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia over 70 Years of Age: On Behalf of the Acute Leukemia Working Party of the EBMT

Author

Ringden, Olle, primary, Boumendil, Ariane, additional, Labopin, Myriam, additional, Canaani, Jonathan, additional, Sadeghi, Behnam, additional, Beelen, Dietrich W., additional, Ehninger, Gerhard, additional, Niederwieser, Dietger, additional, Finke, Jürgen, additional, Stelljes, Matthias, additional, Arnold, Renate, additional, Ganser, Arnold, additional, Kroger, Nicolaus, additional, Kanz, Lothar, additional, Brecht, Arne, additional, Savani, Bipin N., additional, Mohty, Mohamad, additional, and Nagler, Arnon, additional

Published
2018
Full Text
View/download PDF

33. Anti-T Lymphocyte Globulin (ATLG) Improves Quality of Life (QoL) and Chronic Graft vs Host Disease and Relapse Free Survival (GRFS) after Allogeneic Hematopoietic Stem Cell Transplantation from Hla-Identical Sibling in Acute Myeloid Leukemia: Final Results of QoL and Long-Term Outcome Analysis of a Phase 3 Randomized Study

Author

Bonifazi, Francesca, primary, Solano, Carlos, additional, Wolschke, Christine, additional, Sessa, Mariarosaria, additional, Patriarca, Francesca, additional, Zallio, Francesco, additional, Nagler, Arnon, additional, Selleri, Carmine, additional, Risitano, Antonio Maria, additional, Messina, Giuseppe, additional, Bethge, Wolfgang, additional, Herrera, Pilar, additional, Sureda, Anna, additional, Carella, Angelo Michelle, additional, Cimminiello, Michele, additional, Guidi, Stefano, additional, Finke, Jürgen, additional, Sorasio, Roberto, additional, Ferra, Christelle, additional, Sierra, Jorge, additional, Russo, Domenico, additional, Benedetti, Edoardo, additional, Milone, Giuseppe, additional, Benedetti, Fabio, additional, Heinzelmann, Marion, additional, Pastore, Domenico, additional, Jurado, Manuel, additional, Terruzzi, Elisabetta, additional, Narni, Franco, additional, Völp, Andreas, additional, Ayuk, Francis, additional, Ruutu, Tapani, additional, and Kröger, Nicolaus, additional

Published
2018
Full Text
View/download PDF

34. Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial

Author

Ferreri, Andrés J M, primary, Cwynarski, Kate, additional, Pulczynski, Elisa, additional, Fox, Christopher P, additional, Schorb, Elisabeth, additional, La Rosée, Paul, additional, Binder, Mascha, additional, Fabbri, Alberto, additional, Torri, Valter, additional, Minacapelli, Eleonora, additional, Falautano, Monica, additional, Ilariucci, Fiorella, additional, Ambrosetti, Achille, additional, Roth, Alexander, additional, Hemmaway, Claire, additional, Johnson, Peter, additional, Linton, Kim M, additional, Pukrop, Tobias, additional, Sønderskov Gørløv, Jette, additional, Balzarotti, Monica, additional, Hess, Georg, additional, Keller, Ulrich, additional, Stilgenbauer, Stephan, additional, Panse, Jens, additional, Tucci, Alessandra, additional, Orsucci, Lorella, additional, Pisani, Francesco, additional, Levis, Alessandro, additional, Krause, Stefan W, additional, Schmoll, Hans J, additional, Hertenstein, Bernd, additional, Rummel, Mathias, additional, Smith, Jeffery, additional, Pfreundschuh, Michael, additional, Cabras, Giuseppina, additional, Angrilli, Francesco, additional, Ponzoni, Maurilio, additional, Deckert, Martina, additional, Politi, Letterio S, additional, Finke, Jürgen, additional, Reni, Michele, additional, Cavalli, Franco, additional, Zucca, Emanuele, additional, and Illerhaus, Gerald, additional

Published
2017
Full Text
View/download PDF

35. Baseline Characteristics Predicting Very Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Patients With High Cytogenetic Risk Chronic Lymphocytic Leukemia - A Retrospective Analysis From the Chronic Malignancies Working Party of the EBMT

Author

van Gelder, Michel, primary, Ziagkos, Dimitris, additional, de Wreede, Liesbeth, additional, van Biezen, Anja, additional, Dreger, Peter, additional, Gramatzki, Martin, additional, Stelljes, Matthias, additional, Andersen, Niels Smedegaard, additional, Schaap, Nicolaas, additional, Vitek, Antonin, additional, Beelen, Dietrich, additional, Lindström, Vesa, additional, Finke, Jürgen, additional, Passweg, Jacob, additional, Eder, Matthias, additional, Machaczka, Maciej, additional, Delgado, Julio, additional, Krüger, William, additional, Raida, Luděk, additional, Socié, Gerard, additional, Jindra, Pavel, additional, Afanasyev, Boris, additional, Wagner, Eva, additional, Chalandon, Yves, additional, Henseler, Anja, additional, Schoenland, Stefan, additional, Kröger, Nicolaus, additional, and Schetelig, Johannes, additional

Published
2017
Full Text
View/download PDF

36. Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial

Author

Finke, Jürgen, primary, Schmoor, Claudia, additional, Bethge, Wolfgang Andreas, additional, Ottinger, Hellmut, additional, Stelljes, Matthias, additional, Volin, Liisa, additional, Heim, Dominik, additional, Bertz, Hartmut, additional, Grishina, Olga, additional, and Socie, Gerard, additional

Published
2017
Full Text
View/download PDF

37. What Is the Outcome of Patients with Acute Leukemia Who Survive Severe Acute Graft-Versus-Host Disease?

Author

Ringden, Olle, primary, Labopin, Myriam, additional, Mailhol, Audry, additional, Beelen, Dietrich W., additional, Sadeghi, Behnam, additional, Floisand, Yngvar, additional, Ghavamzadeh, Ardeshir, additional, Finke, Jürgen, additional, Ehninger, Gerhard, additional, Volin, Liisa, additional, Ganser, Arnold, additional, Schmid, Christoph, additional, Giebel, Sebastian, additional, and Nagler, Arnon, additional

Published
2017
Full Text
View/download PDF

38. Allogeneic Stem Cell Transplantation for Patients Age ≥ 70 Years with Myelodysplastic Syndrome: A Retrospective Study of the MDS Subcommittee of the Chronic Malignancies Working Party of the EBMT

Author

Heidenreich, Silke, primary, Ziagkos, Dimitris, additional, de Wreede, Liesbeth C., additional, van Biezen, Anja, additional, Finke, Jürgen, additional, Platzbecker, Uwe, additional, Niederwieser, Dietger, additional, Einsele, Hermann, additional, Bethge, Wolfgang, additional, Schleuning, Michael, additional, Beelen, Dietrich W., additional, Tischer, Johanna, additional, Nagler, Arnon, additional, Glass, Bertram, additional, Maertens, Johan, additional, Yáñez, Lucrecia, additional, Beguin, Yves, additional, Sill, Heinz, additional, Scheid, Christof, additional, Stelljes, Matthias, additional, Ganser, Arnold, additional, Zachée, Pierre, additional, Selleslag, Dominik, additional, de Witte, Theo, additional, Robin, Marie, additional, and Kröger, Nicolaus, additional

Published
2017
Full Text
View/download PDF

39. High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial

Author

Illerhaus, Gerald, primary, Kasenda, Benjamin, additional, Ihorst, Gabriele, additional, Egerer, Gerlinde, additional, Lamprecht, Monika, additional, Keller, Ulrich, additional, Wolf, Hans-Heinrich, additional, Hirt, Carsten, additional, Stilgenbauer, Stephan, additional, Binder, Mascha, additional, Hau, Peter, additional, Edinger, Matthias, additional, Frickhofen, Norbert, additional, Bentz, Martin, additional, Möhle, Robert, additional, Röth, Alexander, additional, Pfreundschuh, Michael, additional, von Baumgarten, Louisa, additional, Deckert, Martina, additional, Hader, Claudia, additional, Fricker, Heidi, additional, Valk, Elke, additional, Schorb, Elisabeth, additional, Fritsch, Kristina, additional, and Finke, Jürgen, additional

Published
2016
Full Text
View/download PDF

40. Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network

Author

Hermine, Olivier, primary, Hoster, Eva, additional, Walewski, Jan, additional, Bosly, André, additional, Stilgenbauer, Stephan, additional, Thieblemont, Catherine, additional, Szymczyk, Michal, additional, Bouabdallah, Reda, additional, Kneba, Michael, additional, Hallek, Michael, additional, Salles, Gilles, additional, Feugier, Pierre, additional, Ribrag, Vincent, additional, Birkmann, Josef, additional, Forstpointner, Roswitha, additional, Haioun, Corinne, additional, Hänel, Mathias, additional, Casasnovas, René Olivier, additional, Finke, Jürgen, additional, Peter, Norma, additional, Bouabdallah, Kamal, additional, Sebban, Catherine, additional, Fischer, Thomas, additional, Dührsen, Ulrich, additional, Metzner, Bernd, additional, Maschmeyer, Georg, additional, Kanz, Lothar, additional, Schmidt, Christian, additional, Delarue, Richard, additional, Brousse, Nicole, additional, Klapper, Wolfram, additional, Macintyre, Elizabeth, additional, Delfau-Larue, Marie-Hélène, additional, Pott, Christiane, additional, Hiddemann, Wolfgang, additional, Unterhalt, Michael, additional, and Dreyling, Martin, additional

Published
2016
Full Text
View/download PDF

42. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial

Author

Ferreri, Andrés J M, primary, Cwynarski, Kate, additional, Pulczynski, Elisa, additional, Ponzoni, Maurilio, additional, Deckert, Martina, additional, Politi, Letterio S, additional, Torri, Valter, additional, Fox, Christopher P, additional, Rosée, Paul La, additional, Schorb, Elisabeth, additional, Ambrosetti, Achille, additional, Roth, Alexander, additional, Hemmaway, Claire, additional, Ferrari, Angela, additional, Linton, Kim M, additional, Rudà, Roberta, additional, Binder, Mascha, additional, Pukrop, Tobias, additional, Balzarotti, Monica, additional, Fabbri, Alberto, additional, Johnson, Peter, additional, Gørløv, Jette Sønderskov, additional, Hess, Georg, additional, Panse, Jens, additional, Pisani, Francesco, additional, Tucci, Alessandra, additional, Stilgenbauer, Stephan, additional, Hertenstein, Bernd, additional, Keller, Ulrich, additional, Krause, Stefan W, additional, Levis, Alessandro, additional, Schmoll, Hans J, additional, Cavalli, Franco, additional, Finke, Jürgen, additional, Reni, Michele, additional, Zucca, Emanuele, additional, and Illerhaus, Gerald, additional

Published
2016
Full Text
View/download PDF

44. Allogeneic Stem Cell Transplantation for t(3;3)(q21;q26)/Inv(3)(q21;q26) Acute Myeloid Leukemia – Report from the Acute Leukemia Working Party of the EBMT

Author

Halaburda, Kazimierz, primary, Labopin, Myriam, additional, Houhou, Mohamed, additional, Niederwieser, Dietger, additional, Finke, Jürgen, additional, Volin, Liisa, additional, Maertens, Johan A., additional, Cornelissen, Jan, additional, Milpied, Noel, additional, Stuhler, Gernot, additional, Kröger, Nicolaus, additional, Esteve, Jordi, additional, Mohty, Mohamad, additional, and Nagler, Arnon, additional

Published
2016
Full Text
View/download PDF

45. Sorafenib Promotes Graft-Versus-Leukemia Activity in Mice and Humans through IL-15 Production in Leukemia Cells

Author

Mathew, Nimitha Rose, primary, Baumgartner, Francis, additional, Waterhouse, Miguel, additional, Müller, Tony Andreas, additional, Schmitt-Gräff, Annette, additional, Weber, Arnim, additional, Osswald, Lena, additional, Hanke, Kathrin, additional, Solsona, Sònia Tugues, additional, Spath, Sabine, additional, Pfeifer, Dietmar, additional, Follo, Marie, additional, Claus, Rainer, additional, Lübbert, Michael, additional, Rummelt, Christoph, additional, Bertz, Harmut, additional, Marks, Reinhard, additional, Wäsch, Ralph, additional, Bettinger, Dominik, additional, Schultheiß, Michael, additional, Jilg, Cordula, additional, Ullrich, Evelyn, additional, Tanriver, Yakup, additional, Klose, Christoph S.N., additional, Jung, Manfred, additional, Vuong, Lam, additional, van der Velden, Walter, additional, Thimme, Robert, additional, Blazar, Bruce R., additional, von Bubnoff, Nikolas, additional, Becher, Burkhardt, additional, Duyster, Justus, additional, Häcker, Georg, additional, Finke, Jürgen, additional, Arnold, Renate, additional, Schiedel, Matthias, additional, and Zeiser, Robert, additional

Published
2016
Full Text
View/download PDF

46. Allogeneic Hematopoietic Stem Cell Transplantation for Secondary Acute Myeloid Leukemia- a Report from the Acute Leukemia Working Party of the EBMT

Author

Savani, Bipin N., primary, Labopin, Myriam, additional, Boumendil, Ariane, additional, Ehninger, Gerhard, additional, Ganser, Arnold, additional, Ayuk, Francis, additional, Stelljes, Matthias, additional, Finke, Jürgen, additional, Beelen, Dietrich, additional, Niederwieser, Dietger, additional, Stuhler, Gernot, additional, Glass, Bertram, additional, Arnold, Renate, additional, Polge, Emmanuelle, additional, Gorin, Norbert, additional, Esteve, Jordi, additional, Ciceri, Fabio, additional, Baron, Frédéric, additional, Schmid, Christoph, additional, Giebel, Sebastian, additional, Mohty, Mohamad, additional, and Nagler, Arnon, additional

Published
2016
Full Text
View/download PDF

47. Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis

Author

Nagler, Arnon, primary, Savani, Bipin N, additional, Labopin, Myriam, additional, Polge, Emmanuelle, additional, Passweg, Jakob, additional, Finke, Jürgen, additional, Kyrcz-Krzemien, Slawomira, additional, Volin, Liisa, additional, Anagnostopoulos, Achilles, additional, Aljurf, Mahmoud, additional, Beelen, Dietrich W, additional, Vigouroux, Stephane, additional, Milpied, Noel, additional, Suarez, Felipe, additional, and Mohty, Mohamad, additional

Published
2015
Full Text
View/download PDF

48. Comparison of Unrelated Cord Blood and Peripheral Blood Stem Cell Transplantation in Adults with Myelodysplastic Syndrome after Reduced-Intensity Conditioning Regimen: A Collaborative Study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party

Author

Robin, Marie, primary, Ruggeri, Annalisa, additional, Labopin, Myriam, additional, Niederwieser, Dietger, additional, Tabrizi, Reza, additional, Sanz, Guillermo, additional, Bourhis, Jean-Henri, additional, van Biezen, Anja, additional, Koenecke, Christian, additional, Blaise, Didier, additional, Tischer, Johanna, additional, Craddock, Charles, additional, Maillard, Natacha, additional, Mohty, Mohamad, additional, Russel, Nigel, additional, Schetelig, Johannes, additional, Finke, Jürgen, additional, Gluckman, Eliane, additional, de Witte, Theo M., additional, Rocha, Vanderson, additional, and Kroger, Nicolaus, additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results